Abstract:Introduction: Patients with chronic kidney disease (CKD) are at an alarming risk of fracture compared to age and sex-matched non-CKD individuals. Clinical and preclinical data highlight two key factors in CKD-induced skeletal fragility: cortical porosity and reduced matrix-level properties including bone hydration. Thus, strategies are needed to address these concerns to improve mechanical properties and ultimately lower fracture risk in CKD. We sought to evaluate the singular and combined effects of mechanical and pharmacological interventions on modulating porosity, bone hydration, and mechanical properties in CKD. Methods: Sixteen-week-old male C57BL/6J mice underwent a 10-week CKD induction period via a 0.2 % adenine-laced casein-based diet (n = 48) or remained as non-CKD littermate controls (Con, n = 48). Following disease induction (26 weeks of age), n = 7 CKD and n = 7 Con were sacrificed (baseline cohort) to confirm a steady-state CKD state was achieved prior to the initiation of treatment. At 27 weeks of age, all remaining mice underwent right tibial loading to a maximum tensile strain of 2050 μƐ 3× a week for five weeks with the contralateral limb as a non-loaded control. Half of the mice (equal number CKD and Con) received subcutaneous injections of 0.5 mg/kg raloxifene (RAL) 5× a week, and the other half remained untreated (UN). Mice were sacrificed at 31 weeks of age. Serum biochemistries were performed, and bi-lateral tibiae were assessed for microarchitecture, whole bone and tissue level mechanical properties, and composition including bone hydration. Results: Regardless of intervention, BUN and PTH were higher in CKD animals throughout the study. In CKD, the combined effects of loading and RAL were quantified as lower cortical porosity and improved mechanical, material, and compositional properties, including higher matrix-bound water. Loading was generally responsible for positive impacts in cortical geometry and structural mechanical properties, while RAL treatment improved some trabecular outcomes and material-level mechanical properties and was responsible for improvements in several compositional parameters. While control animals responded positively to loading, their bones were less impacted by the RAL treatment, showing no deformation, toughness, or bound water improvements which were all evident in CKD. Serum PTH levels were negatively correlated with matrix-bound water. Discussion: An effective treatment program to improve fracture risk in CKD ideally focuses on the cortical bone and considers both cortical porosity and matrix properties. Loading-induced bone formation and mechanical improvements were observed across groups, and in the CKD cohort, this included lower cortical porosity. This study highlights that RAL treatment superimposed on active bone formation may be ideal for reducing skeletal complications in CKD by forming new bone with enhanced matrix properties.

Estrogen Deficiency Leads To Further Bone Loss In The Mandible Of Ckd Mice

Mandibular Bone Changes in Ovariectomized Rabbits

Mineralized Bone Loss In Partially Edentulous Trabeculae Of Ovariectomized Rabbit Mandibles

Bone mineral density in mandibles of ovariectomized rabbits.

Effect of Estrogen Deficiency on the Fixation of Titanium Implants in Chronic Kidney Disease Mice.

Ovariectomy-Associated Changes In Bone Mineral Density And Bone Marrow Haematopoiesis In Rats

Dentoalveolar Alterations in an Adenine‐Induced Chronic Kidney Disease Mouse Model

Changes in the MicroRNA Profile of the Mandible of Ovariectomized Mice

Chronic Kidney Disease Impairs Bone Defect Healing in Rats

Effect of Chronic Kidney Disease on the Healing of Titanium Implants.

Bone Marrow Ablation Demonstrates That Estrogen Plays an Important Role in Osteogenesis and Bone Turnover Via an Antioxidative Mechanism

Vitamin D Supplementation Enhances the Fixation of Titanium Implants in Chronic Kidney Disease Mice.

Estrogen deficiency reduces the dentinogenic capacity of rat lower incisors

[Exogenous Estrogen Improved Calcium Homeostasis and Skeletal Mineralization in Vitamin D Receptor Gene Knockout Female Mice].

The Effect of Estrogen Deficiency on Receptor Activator of Nuclear Factor Kappa B Ligand and Osteoprotegerin Synthesis in Periapical Lesions Induced in Rats.

Combining raloxifene and mechanical loading improves bone composition and mechanical properties in a murine model of chronic kidney disease (CKD)

Prevention of Osteoporosis in Mice after Ovariectomy Via Allograft of Microencapsulated Ovarian Cells.

Mild Chronic Kidney Disease Associated with Low Bone Formation and Decrease in Phosphate Transporters and Signaling Pathways Gene Expression

Osteoporosis Affects Both Post-Yield Microdamage Accumulation and Plasticity Degradation in Vertebra of Ovariectomized Rats

FGF23 Neutralization Improves Bone Quality and Osseointegration of Titanium Implants in Chronic Kidney Disease Mice

Effects of oestrogen deficiency on the alveolar bone of rats with experimental periodontitis